{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T20:19:45Z","timestamp":1692735585767},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,20]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n               <jats:p>Antilactoferrin antibodies have been reported in patients with several autoimmune disorders, including primary biliary cirrhosis, autoimmune hepatitis and autoimmune cholangitis. We investigated the prevalence and the clinical significance of such autoreactivity in patients with autoimmune and viral chronic liver disease. Sera from 39 patients with autoimmune hepatitis, 51 with primary biliary cirrhosis, 17 with autoimmune cholangitis, 24 with primary sclerosing cholangitis and 28 with HCV-related chronic hepatitis were studied. Positivity for antilactoferrin antibodies was evaluated by Western immunoblotting with purified human lactoferrin. Antilactoferrin antibodies were detected more often in autoimmune liver disorders (25% autoimmune hepatitis, 25% primary biliary cirrhosis, 35% autoimmune cholangitis, 29% primary sclerosing cholangitis) than in HCV-related chronic hepatitis (3\u00b75%, P\u2003&amp;lt;\u20030\u00b702 versus all). Positivity for antilactoferrin antibodies was not associated with a particular clinical or biochemical profile of the underlying liver disease. No correlation was observed between antilactoferrin reactivity and perinuclear antineutrophil cytoplasmic antibodies. Antilactoferrin antibodies are present significantly more often in autoimmune than in viral liver disorders, but they cannot be considered the serological marker of a specific autoimmune liver disease.<\/jats:p>","DOI":"10.1046\/j.1365-2249.2001.01524.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:27:49Z","timestamp":1047378469000},"page":"470-473","source":"Crossref","is-referenced-by-count":20,"title":["Antilactoferrin antibodies in autoimmune liver disease"],"prefix":"10.1093","volume":"124","author":[{"given":"L","family":"Muratori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Zauli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Policlinico S. Orsola-Malpighi, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Grassi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Policlinico S. Orsola-Malpighi, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Pappas","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Policlinico S. Orsola-Malpighi, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Rodrigo","sequence":"additional","affiliation":[{"name":"Gastroenterology Service, Hospital Central de Asturias, Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Cassani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Policlinico S. Orsola-Malpighi, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Lenzi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Policlinico S. Orsola-Malpighi, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F B","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Policlinico S. Orsola-Malpighi, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"2022011305533266100_b1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1515\/CCLM.1999.049","article-title":"Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process","volume":"37","author":"Baveye","year":"1999","journal-title":"Clin Chem Lab Med"},{"key":"2022011305533266100_b2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"key":"2022011305533266100_b3","first-page":"581","article-title":"autoantibodies in rheumatoid arthritis","volume":"11","author":"Esaguy","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"2022011305533266100_b4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/03009749409103062","article-title":"Occurrence of antibodies in patients with systemic lupus erythematosus, hydralazine-induced lupus, and rheumatoid arthritis","volume":"23","author":"Nassberger","year":"1994","journal-title":"Scand J Rheumatol"},{"key":"2022011305533266100_b5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1046\/j.1365-2249.1999.01008.x","article-title":"antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis","volume":"117","author":"Locht","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2022011305533266100_b6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-4757-9068-9_39","article-title":"Prevalence and clinical significance of autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis","volume":"443","author":"Roozendaal","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"2022011305533266100_b7","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/j.1572-0241.1998.444_n.x","article-title":"Antilactoferrin antibodies in autoimmune liver diseases","volume":"93","author":"Ohana","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"2022011305533266100_b8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: Intenational Autoimmune Hepatitis Group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"2022011305533266100_b9","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"2022011305533266100_b10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"N Engl J Med"},{"key":"2022011305533266100_b11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2007-1007183","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis","volume":"17","author":"Leung","year":"1997","journal-title":"Semin Liver Dis"},{"key":"2022011305533266100_b12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","article-title":"Serum autoantibodies in chronic hepatitis C. comparison with autoimmune hepatitis and impact on the disease profile","volume":"26","author":"Cassani","year":"1997","journal-title":"Hepatology"},{"key":"2022011305533266100_b13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.37.3.406","article-title":"Heterogeneity of liver\/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease","volume":"37","author":"Muratori","year":"1995","journal-title":"Gut"},{"key":"2022011305533266100_b14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-1759(95)00192-X","article-title":"Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques","volume":"187","author":"Muratori","year":"1995","journal-title":"J Immunol Methods"},{"key":"2022011305533266100_b15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510250510","article-title":"Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis","volume":"25","author":"Zauli","year":"1997","journal-title":"Hepatology"},{"key":"2022011305533266100_b16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.510280207","article-title":"Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins","volume":"28","author":"Terjung","year":"1998","journal-title":"Hepatology"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01524.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01524.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/124\/3\/470\/42162543\/j.1365-2249.2001.01524.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/124\/3\/470\/42162543\/j.1365-2249.2001.01524.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:49:51Z","timestamp":1676375391000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/124\/3\/470\/6461400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2001,12,20]]},"published-print":{"date-parts":[[2001,12,20]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.2001.01524.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,6]]},"published":{"date-parts":[[2001,6]]}}}